Location History:
- Paris, FR (2010)
- Antony, FR (2011)
Company Filing History:
Years Active: 2010-2011
Title: Michel Aletru: Innovator in Pharmaceutical Chemistry
Introduction
Michel Aletru is a notable inventor based in Antony, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that modulate enzyme activity. With a total of 3 patents to his name, Aletru's work is recognized for its potential therapeutic applications.
Latest Patents
Among his latest patents, Aletru has developed a compound related to substituted quinoxalines, which are utilized as 11β-HSD1 modulators. This invention focuses on a specific compound formula, which is crucial for treating diseases associated with the enzyme 11β-HSD1. Another significant patent involves urea derivatives of tropane, which also serve as modulators of the 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) activity. These innovations highlight Aletru's commitment to advancing therapeutic solutions in medicine.
Career Highlights
Michel Aletru is currently associated with Sanofi-Aventis, a leading global healthcare company. His role at Sanofi-Aventis allows him to collaborate with other experts in the field and contribute to groundbreaking research and development in pharmaceuticals.
Collaborations
Throughout his career, Aletru has worked alongside talented colleagues, including Claudie Namane and Christophe Philippo. These collaborations have fostered an environment of innovation and have led to the successful development of new therapeutic compounds.
Conclusion
Michel Aletru's contributions to pharmaceutical chemistry through his patents and collaborations underscore his role as an influential inventor in the industry. His work continues to pave the way for advancements in therapeutic applications, benefiting the medical community and patients alike.